A recent study indicates that individuals who discontinue blockbuster slimming jabs like semaglutide or tirzepatide tend to recover shed pounds at a significantly accelerated pace than those who halt conventional lifestyle programs.
Findings released in a major medical journal demonstrates that while overweight individuals frequently drop substantial amounts of their body weight while using the jabs, the weight comes back at an average rate of nearly a kilo each month once they quit.
"Users purchasing such drugs need to be informed of the risk of rapid weight regain when the treatment ends," cautioned expert Dr. Susan Jebb.
That rate of regain implies a return to original weight within about one and a half years.
Comparing Treatments
The research, which looked at dozens of studies involving thousands of participants, compared the results of these new drugs with older methods.
Scientists emphasize that people who shed pounds through dieting typically experience a slower weight regain—approximately 100 grams monthly—once they finish.
The Reason for the Rapid Regain
Experts propose the mechanism of the drugs explains the accelerated weight return.
The injections copy a natural hormone called GLP-1, which controls appetite.
"Artificially providing GLP-1 levels several times higher than the body's typical production could lead to the body to generate a reduced amount of its endogenous GLP-1, and could diminish sensitivity to its actions," said Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this GLP-1 'fix' results in hunger is no longer kept in check, making binge eating far more likely."
A Chronic Issue?
The NHS advise the injections for people with weight-linked medical conditions, alongside recommended diet and exercise modifications.
Professionals contend that, given the significant potential of weight regain, the treatment should be considered life-long.
This perspective is echoed by drug manufacturers, who note that the results "underscore the long-term nature of obesity," akin to managing diseases like diabetes.
User Accounts
Individuals who have come off the jabs report a intense resurgence of cravings.
"I experienced something flipping and you're instantly starving," recalled a patient.
This difficulty is worsened if individuals have not developed permanent lifestyle or habit modifications during therapy.
Significant Use
Figures indicate that a significant number of people in the UK have tried these injections in the last 12 months, with demand continuing to grow.
- Use is more common among women than males.
- The 40s and 50s age group shows the highest usage rates.
- A large proportion access the medications through private prescriptions rather than the NHS.
Ultimately, experts emphasize that while these medications are effective tools for weight loss, they are not a magic solution and lasting health benefits hinges on combined behavioural support.
